Impaired blood–brain barrier function in angiotensinogen-deficient mice

Abstract

Astrocytes in the central nervous system have physiologically important roles in the response to brain injury 1, 2 . Brain damage results in disruption of the blood–brain barrier (BBB), producing detachment of astrocyte endfeet from endothelial cells 3 . The resultant leakage of serum proteins from loosened tight junctions between endothelial cells produces brain edema. At the same time, reactive astrocytes migrate to the injured area, where they proliferate and produce extracellular matrix 4, 5, 6 , thereby reconstituting the BBB. As astrocytes are known to express angiotensinogen 7, 8 , which is the precursor of angiotensins (AI to AIV), we have investigated a possible functional contribution of angiotensinogen or one of its metabolites to BBB reconstitution. The astrocytes of angiotensinogen knockout mice had very attenuated expression of glial fibrially acidic protein and decreased laminin production in response to cold injury, and ultimately incomplete reconstitution of impaired BBB function. Although these abnormalities were rescued by administration of AII or AIV, the restoration of BBB function was not inhibited by AII type 1 and 2 receptor antagonists. These findings provide evidence that astrocytes with angiotensins are required for functional maintenance of the BBB.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Cold-injured brains of WT and Agt-KO mice after Evans blue administration.
Figure 2: Expression of GFAP and laminin in astrocytes of WT and Agt-KO mice.
Figure 3: Effects of AII, AIV or DB-cAMP on adhesion and morphological changes in astrocytes from WT and Agt-KO mice.
Figure 4: Effects of AII and AIV on BBB reconstruction.

References

  1. 1

    Nieto-Sampedro, M., Saneto, R.P., De Vellis, J. & Cotman, C.W. The control of glial populations in brain: Changes in astrocyte mitogenic and morphogenic factors in response to injury. Brain Res. 343, 320–328 (1985).

    CAS  Article  Google Scholar 

  2. 2

    Norenberg, M.D. Astrocyte responses to CNS injury. J. Neuropathol. Exp. Neurol. 53, 213–220 ( 1994).

    CAS  Article  Google Scholar 

  3. 3

    Janzer, R.C. & Raff, M.C. Astrocytes induce blood–brain barrier properties in endothelial cells. Nature 325 , 253–257 (1987).

    CAS  Article  Google Scholar 

  4. 4

    Ludwin, SK. Reaction of oligodendrocytes and astrocytes to trauma and implantation. Lab. Invest. 53, 20 –30 (1985).

  5. 5

    Laywell, E.D. et al. Enhanced expression of the developmentally regulated extracellular matrix molecule tenasin following adult brain injury. Proc. Natl. Acad. Sci. USA 89, 2634–2638 (1992).

    CAS  Article  Google Scholar 

  6. 6

    Reier, P.J. in Cell Biology and Pathology of Astrocytes (ed. Waxman, S.G.) 263 –324 (Academic, Orlando, Florida 1986 ).

    Google Scholar 

  7. 7

    Stornetta, R.L., Hawelu-Johnson, C.L., Guyenet, P.G. & Lynch, K.R. Astrocytes synthesize angiotensinogen in brain. Science 242, 1444–1446 (1988).

    CAS  Article  Google Scholar 

  8. 8

    Milsted, A., Barna, B.P., Ransohof, R.M., Brosnihan, K.B. & Ferrario, C.M. Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA. Proc. Natl. Acad. Sci. USA 87, 5720–5723 ( 1990).

    CAS  Article  Google Scholar 

  9. 9

    Tanimoto, K. et al. Angiotensinogen-deficient mice with hypotension. J. Biol. Chem. 269, 31334–31337 (1994).

    CAS  Google Scholar 

  10. 10

    Sugiyama, F. et al. Speedy backcrossing through in vitro fertilization, using pre-pubertal superovulation and neonatal death dependent on genetic background in angiotensinogen-deficient mice. Lab. Anim. Sci. 47, 545–548 (1997).

    CAS  PubMed  Google Scholar 

  11. 11

    Chan, P.H., Longar, S. & Fishman, R.A. Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema. Ann. Neurol. 21, 540–547 (1987).

    CAS  Article  Google Scholar 

  12. 12

    Hama, H. et al. Role of endothelin-1 in astrocyte responses after acute brain damage. J. Neurosci. Res. 47, 590– 602 (1997).

    CAS  Article  Google Scholar 

  13. 13

    Liedtke, W. et al. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17 , 607–615 (1996).

    CAS  Article  Google Scholar 

  14. 14

    Goldstein, G.W. & Betz, A.L. The blood–brain barrier. Sci. Am. 255, 70– 83 (1986).

    Article  Google Scholar 

  15. 15

    Le-Prince, G., Fages, C., Rolaand, B., Nunez, J. & Tardy, M. DBcAMP effect on the expression of GFAP and of its encoding mRNA in astroglial primary culture. Glia 4, 322–326 (1991).

    CAS  Article  Google Scholar 

  16. 16

    Eng, L.F. & Ghirnikar, R.S. GFAP and astrogliosis. Brain Pathol. 4, 229–237 (1994).

    CAS  Article  Google Scholar 

  17. 17

    Wright, J.W. et al. The angiotensin IV system: functional implications. Front. Neuroendocrinol. 16, 23–52 (1995).

    CAS  Article  Google Scholar 

  18. 18

    Roberts, K.A. et al. Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats. Brain Res. 682, 13–21 (1995).

    CAS  Article  Google Scholar 

  19. 19

    Miller-Wing, A.V., et al. Central angiotensin IV binding sites: distribution and specificity in guinea pig brain. J. Pharmacol. Exp. Ther. 266, 1718–1726 (1993).

    CAS  PubMed  Google Scholar 

  20. 20

    Moeller, I. et al. Distribution of AT4 receptors in the Macaca fascicularis brain. Brain Res. 712, 307– 324 (1996).

    CAS  Article  Google Scholar 

  21. 21

    De Oliveira, A.M., Viswanathan, M., Heemskerk, F.M.J. & Saavedra, J.M. Expression of a novel angiotensin II receptor subtype in gerbil brain. Brain Res. 705, 177–187 (1995).

    CAS  Article  Google Scholar 

  22. 22

    Shibouta, Y. et al. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug (+/-)-1- (cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116). J. Pharmacol. Exp. Ther. 266, 114–120 (1993).

    CAS  PubMed  Google Scholar 

  23. 23

    Dudley, D.T. et al. Subclasses of angiotensin II binding sites and their functional significance. Mol. Pharmacol. 38, 370– 377 (1990).

    CAS  PubMed  Google Scholar 

  24. 24

    Wright, J.W., Bechtholt, A.J., Chambers, S.L. & Harding, J.W. Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function. Peptides 17, 1365– 1371 (1996).

    CAS  Article  Google Scholar 

  25. 25

    Warnick, R.E. et al. Measurement of vascular permeability in spinal cord using Evans Blue spectrophotometry and correction for turbidity. J. Neurosci. Methods 58, 167–171 ( 1995).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the 'Research for the Future' Program (The Japan Society for the Promotion of Science: JSPS―RFTF 97L00804), the Ministry of Education, Science, Sports, and Culture, The Mitsubishi Foundation, Uehara Memorial Foundation, Kanae Foundation of Research for New Medicine, The Inamori Foundation, The Asahi Glass Foundation, The Naito Foundation, The Mochida Memorial Foundation for Medical and Pharmaceutical Research, and The Nissan Science Foundation. We acknowledge our laboratory members for discussions and encouragement.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Akiyoshi Fukamizu.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kakinuma, Y., Hama, H., Sugiyama, F. et al. Impaired blood–brain barrier function in angiotensinogen-deficient mice. Nat Med 4, 1078–1080 (1998). https://doi.org/10.1038/2070

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing